المؤلفون: Hiyam Al-Jabr, Karen Windle, Andrew Clifton, David R Thompson, David J Castle, Chantal F Ski

المصدر: BJGP Open, Vol 8, Iss 1 (2024)

مصطلحات موضوعية: long covid, post-acute covid-19 syndrome, mental health, optimal health programme, primary health care, feasibility studies, qualitative research, Medicine (General), R5-920

الوصف: Background: Long COVID (LC) symptoms persist 12 weeks or more beyond the acute infection. To date, no standardised diagnostic or treatment pathways exist. However, a holistic approach has been recommended. This study explored participants’ experiences of a Long COVID–Optimal Health Programme (LC–OHP); a psychoeducational self-efficacy programme. Aim: To explore perceptions and experiences of people with LC regarding the LC-OHP and identify suggestions to further improve the programme. Design & setting: Qualitative study with patients with LC recruited through community settings. Method: This study is part of a wider randomised controlled trial. Eligible participants were aged ≥18 years, have LC, and attended a minimum of five LC–OHP sessions plus a booster session. We interviewed those randomised to the intervention group. Interviews were conducted by an independent researcher and thematically analysed to identify common, emerging themes. Results: Eleven participants were interviewed, mostly women from a White British ethnic group (n = 10). Four main themes were identified, reflecting programme benefits and suggestions for improvement. The programme demonstrated potential for assisting patients in managing their LC, including physical health and mental wellbeing. Participants found the programme to be flexible and provided suggestions to adapting it for future users. Conclusion: Findings support the acceptability of the LC–OHP to people living with LC. The programme has shown several benefits in supporting physical health and mental wellbeing. Suggestions made to further adapt the programme and improve its delivery will be considered for future trials.

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2398-3795Test

الوصول الحر: https://doaj.org/article/5cf02fc811474d259963e04eea6a7040Test

المؤلفون: Kaitlyn Crocker, Inge Gnatt, Darren Haywood, Ravi Bhat, Ingrid Butterfield, Anoop Raveendran Nair Lalitha, Ruby Bishop, David J Castle, Zoe M Jenkins

المصدر: JMIR Research Protocols, Vol 12, p e48855 (2023)

مصطلحات موضوعية: Medicine, Computer applications to medicine. Medical informatics, R858-859.7

الوصف: BackgroundA large proportion of Australians are affected by mental illness each year, and treatment gaps are well known. To meet current and future demands and enable access to treatment that is safe, effective, and acceptable, a robust and sustainable mental health workforce is required. Factors reported to attract people to work within the mental health sector include aspiring to help others, having an interest in mental health and human behavior, the desire to make a difference and do something worthwhile, personal lived experience, recognition, and value of discipline-specific roles. However, despite the various reasons people enter the public mental health workforce, recruitment and retention continue to be ongoing challenges. To date, there has been limited investigation into understanding which factors are most relevant to the current Victorian workforce. Furthermore, a comparison to health care workers outside of mental health is also needed to better understand the specific needs of staff within the mental health sector. ObjectiveThis study aims to explore factors related to attraction, recruitment, and retention of the public mental health workforce in Victoria, Australia. MethodsThe study is a multisite, mixed methods cross-sectional study to be conducted at 4 public hospital services within Victoria, Australia: 2 in metropolitan and 2 in regional or rural locations. Current, previous, and nonmental health workers will be asked to complete a 20-25–minute web-based survey, which is developed based on previous research and offered participation in an optional 30-60–minute semistructured interview to examine personal experiences and perceptions. Both aspects of the project will examine factors related to attraction, recruitment, and retention in the public mental health workforce. Differences between groups (ie, current, past, and nonmental health workers), as well as location, discipline, and health setting will be examined. Regression analyses will be performed to determine the factors most strongly associated with retention (ie, job satisfaction) and turnover intention. Qualitative data will be transcribed verbatim and thematically analyzed to identify common themes. ResultsAs of May 2023, we enrolled 539 participants in the web-based survey and 27 participants in the qualitative interview. ConclusionsThis project seeks to build on current knowledge from within Australia and internationally to understand role and service/system-related issues of attraction, recruitment, and retention specifically within Victoria, Australia. Seeking up-to-date information from across the health workforce may provide factors specific to mental health by illuminating any differences between mental health workers and health care workers outside of mental health. Furthermore, exploring motivators across health care disciplines and locations to enter, stay in, or leave a role in public mental health settings will provide valuable information to support how the sector plans and develops strategies that are fit for purpose. International Registered Report Identifier (IRRID)DERR1-10.2196/48855

وصف الملف: electronic resource

العلاقة: https://www.researchprotocols.org/2023/1/e48855Test; https://doaj.org/toc/1929-0748Test

الوصول الحر: https://doaj.org/article/6dc3f6b4a57b41088dfaae3f497dee02Test

المؤلفون: Hiyam Al-Jabr, Karen Windle, David R Thompson, Zoe M Jenkins, David J Castle, Chantal F Ski

المصدر: JMIR Research Protocols, Vol 11, Iss 5, p e36673 (2022)

مصطلحات موضوعية: Medicine, Computer applications to medicine. Medical informatics, R858-859.7

الوصف: BackgroundLong COVID is a collection of symptoms that develop during or following a confirmed or suspected case of COVID-19, which continue for more than 12 weeks. Despite the negative impact of long COVID on people’s lives and functioning, there is no validated treatment or even rehabilitation guidance. What has been recommended thus far is the adoption of holistic management approaches. The Optimal Health Program (OHP) is a brief 5-session, plus booster, psychosocial program designed to support mental and physical well-being that has been used effectively for a range of chronic conditions. ObjectiveThis study examines the feasibility and acceptability of employing an especially customized version of OHP (long COVID OHP [LC-OHP]) to improve psychological and physical health of people with long COVID. MethodsThis is a feasibility randomized controlled trial that will be running from November 2021 to February 2023. Eligible participants aged 18 years or older who are experiencing symptoms of long COVID will be identified through their secondary practitioners with recruitment to be undertaken by the research team. A total of 60 participants will be randomized into a control (usual care) or an intervention (LC-OHP) group. Outcomes will be feasibility and acceptability of the program (primary); and efficacy of the LC-OHP in improving anxiety, depression, fatigue, self-efficacy, and quality of life (secondary). Up to 20 participants will be interviewed at the end of the trial to explore their experience with the program. Quantitative data will be analyzed using SPSS, and differences between groups will be compared using inferential tests where appropriate. Qualitative data will be transcribed and thematically analyzed to identify common emerging themes. ResultsThis is an ongoing study, which began in November 2021. ConclusionsLong COVID has a significant impact on an individual’s mental and physical functioning. The LC-OHP has a potential to provide people living with long COVID with additional support and to improve self-efficacy. The findings of this study would identify the feasibility of delivering this program to this population and will provide an indication for the program’s effectiveness. Trial RegistrationISRCTN Registry ISRCTN38746119; https://www.isrctn.com/ISRCTN38746119Test International Registered Report Identifier (IRRID)DERR1-10.2196/36673

وصف الملف: electronic resource

العلاقة: https://www.researchprotocols.org/2022/5/e36673Test; https://doaj.org/toc/1929-0748Test

الوصول الحر: https://doaj.org/article/a1003795de9f457a98a88addd7c7de2aTest

المؤلفون: Ryan A Kaplan, Peter G Enticott, Jakob Hohwy, David J Castle, Susan L Rossell

المصدر: PLoS ONE, Vol 9, Iss 6, p e99981 (2014)

مصطلحات موضوعية: Medicine, Science

الوصف: Evidence from past research suggests that behaviours and characteristics related to body dissatisfaction may be associated with greater instability of perceptual body image, possibly due to problems in the integration of body-related multisensory information. We investigated whether people with body dysmorphic disorder (BDD), a condition characterised by body image disturbances, demonstrated enhanced susceptibility to the rubber hand illusion (RHI), which arises as a result of multisensory integration processes when a rubber hand and the participant's hidden real hand are stimulated in synchrony. Overall, differences in RHI experience between the BDD group and healthy and schizophrenia control groups (n = 17 in each) were not significant. RHI strength, however, was positively associated with body dissatisfaction and related tendencies. For the healthy control group, proprioceptive drift towards the rubber hand was observed following synchronous but not asynchronous stimulation, a typical pattern when inducing the RHI. Similar drifts in proprioceptive awareness occurred for the BDD group irrespective of whether stimulation was synchronous or not. These results are discussed in terms of possible abnormalities in visual processing and multisensory integration among people with BDD.

وصف الملف: electronic resource

العلاقة: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24925079/?tool=EBITest; https://doaj.org/toc/1932-6203Test

الوصول الحر: https://doaj.org/article/eba7691898c9432a8b207e984c4a031cTest

المؤلفون: Debra L Foley, Andrew Mackinnon, Gerald F Watts, Jonathan E Shaw, Dianna J Magliano, David J Castle, John J McGrath, Anna Waterreus, Vera A Morgan, Cherrie A Galletly

المصدر: PLoS ONE, Vol 8, Iss 12, p e82606 (2013)

مصطلحات موضوعية: Medicine, Science

الوصف: Individuals with psychosis are more likely than the general community to develop obesity and to die prematurely from heart disease. Interventions to improve cardiovascular outcomes are best targeted at the earliest indicators of risk, at the age they first emerge. We investigated which cardiometabolic risk indicators distinguished those with psychosis from the general population, by age by gender, and whether obesity explained the pattern of observed differences. Data was analyzed from an epidemiologically representative sample of 1,642 Australians with psychosis aged 18-64 years and a national comparator sample of 8,866 controls aged 25-64 years from the general population. Cubic b-splines were used to compare cross sectional age trends by gender for mean waist circumference, body mass index [BMI], blood pressure, fasting blood glucose, triglycerides, LDL, HDL, and total cholesterol in our psychosis and control samples. At age 25 individuals with psychosis had a significantly higher mean BMI, waist circumference, triglycerides, glucose [women only], and diastolic blood pressure and significantly lower HDL-cholesterol than controls. With the exception of triglycerides at age 60+ in men, and glucose in women at various ages, these differences were present at every age. Differences in BMI and waist circumference between samples, although dramatic, could not explain all differences in diastolic blood pressure, HDL-cholesterol or triglycerides but did explain differences in glucose. Psychosis has the hallmarks of insulin resistance by at least age 25. The entire syndrome, not just weight, should be a focus of intervention to reduce mortality from cardiovascular disease.

وصف الملف: electronic resource

العلاقة: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24367528/?tool=EBITest; https://doaj.org/toc/1932-6203Test

الوصول الحر: https://doaj.org/article/8083a09b9b07464dacb36e9738c98365Test

المؤلفون: Eugene Allers, Christer Allgulander, Sean Exner Baumann, Charles L Bowden, P Buckley, David J Castle, Beatrix J Coetzee, Franco Colin, A M Dikobe, Charl Els, Robin Emsley, Senathi Fisha, A E Gangat, T Goba, Gerhard Grundling, Jürgen Harms, S M Hawkridge, Erick Hollander, M L Janet, A B R Janse van Rensburg, Shabeer Ahmed Jeeva, J A Joska, Andre Joubert, Sean Z Kaliski, V N Khanyile, Fred Kigozi, B Levinson, Marilyn Lucas, E N Madela-Mntla, M Y H Moosa, Piet Oosthuizen, Ted Parran, A Pauw, Willie Pienaar, Felix Potocnik, Ramovha Rachel, J. L Roos, Steven P Roose, Martin Scholtz, Soraya Seedat, M Spitzer, Dan J Stein, Ugash Subramaney, Dave Swingler, Christopher Paul Szabo, Godfrey B Tangwa, Michael Trimble, H van der Bijl, L M van der Merwe, Vasi van Deventer, C W van Staden, W J C Verbeeck, G C Verster, Merryll Vorster, Bruce Lydiard

المصدر: South African Journal of Psychiatry, Vol 10, Iss 3 (2004)

مصطلحات موضوعية: Psychiatry, RC435-571

الوصف: List of abstacts and authors: 1. Integrating the art and science of psychiatry Eugene Allers 2. Chronic pain as a predictor of outcome in an inpatient Psychiatric population Eugene Allers and Gerhard Grundling 3. Recent advances in social phobia Christer Allgulander 4. Clinical management of patients with anxiety disorders Christer Allgulander 5. Do elephants suffer from Schizophrenia? (Or do the Schizophrenias represent a disorder of self consciousness?) A Southern African perspective Sean Exner Baumann 6. Long term maintenance treatment of Bipolar Disorder: Preventing relapse Charles L. Bowden 7. Predictors of response to treatments for Bipolar Disorder Charles L. Bowden 8. Aids/HIV knowledge and high risk behaviour: A Geo-graphical comparison in a schizophrenia population P Buckley, S van Vuuren, L Koen, J E Muller, C Seller, H Lategan, D J H Niehaus 9. Does Marijuana make you go mad? David J Castle 10. Understanding and management of Treatment Resistant Schizophrenia David J Castle 11. Workshop on research and publishing David J Castle 12. From victim to victor: Without a self-help book Beatrix Jacqueline Coetzee 13. The evaluation of the Gender Dysphoric patient Franco Colin 14. Dissociation: A South African model A M Dikobe, C K Mataboge, L M Motlana, B F Sokudela, C Kruger 15. Designated smoking rooms...and other "Secret sins" of psychiatry: Tobacco cessation approaches in the severely mentally ill Charl Els 16. Dual diagnosis: Implications for treatment and prognosis Charl Els 17. Body weight, glucose metabolism and the new generation antipsychotics Robin Emsley 18. Neurological abnormalities in first episode Schizophrenia: Temporal stability and clinical and outcome correlates Robin Emsley, H Jadri Turner, Piet P Oosthuizen, Jonathan Carr 19. Mythology of depressive illnesses among Africans Senathi Fisha 20. Substance use and High school dropout Alan J. Flisher, Lorraine Townsend, Perpetual Chikobvu, Carl Lombard, Gary King 21. Psychosis and Psychotic disorders A E Gangat 22. Vulnerability of individuals in a family system to develop a psychiatric disorder Gerhard Grundling and Eugene Allers 23. What does it Uberhaupt mean to "Integrate"? Jürgen Harms 24. Research issues in South African child and adolescent psychiatry S M Hawkridge 25. New religious movements and psychiatry: The Good News V H Hitzeroth 26. The pregnant heroin addict: Integrating theory and practice in the development and provision of a service for this client group V H Hitzeroth, L Kramer 27. Autism spectrum disorder Erick Hollander 28. Recent advances and management in treatment resistance Eric Hollander 29. Bipolar mixed states M. Leigh Janet 30. Profile of acute psychiatric inpatients tested for HIV - Helen Jospeh Hospital, Johannesburg A B R Janse van Rensburg 31. ADHD - Using the art of film-making as an education medium Shabeer Ahmed Jeeva 32. Treatment of adult ADHD co-morbidities Shabeer Ahmed Jeeva 33. Needs and services at ward one, Valkenberg Hospital Dr J. A. Joska, Prof. A.J. Flisher 34. Unanswered questions in the adequate treatment of depression Moderator: Dr Andre F Joubert Expert: Prof. Tony Hale 35. Unanswered questions in treatment resistant depression Moderator: Dr Andre F Joubert Expert: Prof. Sidney Kennedy 36. Are mentally ill people dangerous? Sen Z Kaliski 37. The child custody circus Sean Z. Kaliski 38. The appropriatenes of certification of patients to psychiatric hospitals V. N. Khanyile 39. HIV/Aids Psychosocial responses and ethical dilemmas Fred Kigozi 40. Sex and Psychiatry B Levinson 41. Violence and abuse in psychiatric in-patient institutions: A South African perspective Marilyn Lucas, John Weinkoove, Dean Stevenson 42. Public health sector expenditure for mental health - A baseline study for South Africa E N Madela-Mntla 43. HIV in South Africa: Depression and CD4 count M Y H Moosa, F Y Jeenah 44. Clinical strategies in dealing with treatment resistant schizophrenia Piet Oosthuizen, Dana Niehaus, Liezl Koen 45. Buprenorphine/Naloxone maintenance in office practice: 18 months and 170 patients after the American release Ted Parran Jr, Chris Adelman 46. Integration of Pharmacotherapy for Opioid dependence into general psychiatric practice: Naltrexone, Methadone and Buprenorphine/ Naloxone Ted Parran 47. Our African understanding of individulalism and communitarianism Willie Pienaar 48. Healthy ageing and the prevention of Dementia Felix Potocnik, Susan van Rensburg, Christianne Bouwens 49. Indigenous plants and methods used by traditional African healers for treatinf psychiatric patients in the Soutpansberg Area (Research was done in 1998) Ramovha Muvhango Rachel 50. Symptom pattern & associated psychiatric disorders in subjects with possible & confirmed 22Q11 deletional syndrome J.L. Roos, H.W. Pretorius, M. Karayiorgou 51. Duration of antidepressant treatment: How long is long enough? How long is too long Steven P Roose 52. A comparison study of early non-psychotic deviant behaviour in the first ten years of life, in Afrikaner patients with Schizophrenia, Schizo-affective disorder and Bipolar disorder Martin Scholtz, Melissa Janse van Rensburg, J. Louw Roos 53. Treatment, treatment issues, and prevention of PTSD in women: An update Soraya Seedat 54. Fron neural networks to clinical practice M Spitzer 55. Opening keynote presentation: The art and science of Psychiatry M Spitzer 56. The future of Pharmacotherapy for anxiety disorders Dan J. Stein 57. Neuropsychological deficits pre and post Electro Convulsive Therapy (ECT) thrice a week: A report of four cases Ugash Subramaney, Yusuf Moosa 58. Prevalence of and risk factors for Tradive Dyskinesia in a Xhosa population in the Eastern Cape Dave Singler, Betty D. Patterson, Sandi Willows 59. Eating disorders: Addictive disorders? Christopher Paul Szabo 60. Ethical challenges and dilemmas of research in third world countries Godfrey B. Tangwa 61. The interface between Neurology and Psychiatry with specific focus on Somatoform dissociative disorders Michael Trimble 62. Prevalence and correlates of depression and anxiety in doctors and teachers H Van der Bijl, P Oosthuizen 63. Ingrid Jonker: A psychological analysis L. M. van der Merwe 64. The strange world we live in, and the nature of the human subject Vasi van Deventer 65. Art in psychiatry: Appendix or brain stem? C W van Staden 66. Medical students on what "Soft skills" are about before and after curriculum reform C W van Staden, P M Joubert, A-M Bergh, G E Pickworth, W J Schurink, R R du Preez, J L Roos, C Kruger, S V Grey, B G Lindeque 67. Attention deficit hyperactivity disorder (ADHD) - Medical management. Methylphenidate (Ritalin) or Atomoxetine (Strattera) Andre Venter 68. A comprehensive guide to the treatment of adults with ADHD W J C Verbeeck 69. Treatment of Insomnia: Stasis of the Art? G C Verster 70. Are prisoners vulnerable research participants? Merryll Vorster 71. Psychiatric disorders in the gym Merryl Vorster 72. Ciprales: Effects on anxiety symptoms in Major Depressive Disorder Bruce Lydiard

وصف الملف: electronic resource

العلاقة: http://www.sajp.org.za/index.php/sajp/article/view/150Test; https://doaj.org/toc/1608-9685Test; https://doaj.org/toc/2078-6786Test

الوصول الحر: https://doaj.org/article/085f8b8a57ed4d6bbfdf8ac87fe50019Test

المؤلفون: Sarah N. Brennan, Susan L. Rossell, Imogen Rehm, Neil Thomas, David J. Castle

المصدر: Frontiers in Psychiatry, Vol 14 (2023)

مصطلحات موضوعية: Body Dysmorhic Disorder, lived experience, intolerance of uncertainty, qualitative research, the flawed self, consumed by the disorder, Psychiatry, RC435-571

الوصف: Body Dysmorphic Disorder (BDD) is characterized by an intense preoccupation with one or more perceived “defects” in physical appearance. Despite the distress and impairment associated with BDD, the disorder remains understudied and poorly understood. In particular, there are limited studies available which give voice to those with firsthand experiences of the disorder. A qualitative approach was employed to study lived experience of BDD. In-depth semi-structured interviews were conducted with 12 participants with BDD, aiming to understand their subjective experiences of the disorder. Data was analyzed using Interpretative Phenomenological Analysis (IPA). The results identified three superordinate themes; (1) consumed by the disorder, (2) the flawed self, and (3) intolerance of uncertainty about appearance. The qualitative findings of this study are discussed in relation to current conceptual understandings of BDD, including the cognitive behavioral model.

العلاقة: https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1214803/fullTest; https://doaj.org/toc/1664-0640Test; https://doaj.org/article/10dc58c79f134346b6b8aaf1371c9868Test

الإتاحة: https://doi.org/10.3389/fpsyt.2023.1214803Test
https://doaj.org/article/10dc58c79f134346b6b8aaf1371c9868Test

المؤلفون: Muhammad Ishrat Husain, Daniel M. Blumberger, David J. Castle, Nicole Ledwos, Elise Fellows, Brett D. M. Jones, Abigail Ortiz, Stefan Kloiber, Wei Wang, Joshua D. Rosenblat, Benoit H. Mulsant

المصدر: BJPsych Open, Vol 9 (2023)

مصطلحات موضوعية: Treatment-resistant depression, major depressive disorder, psilocybin, randomised controlled trial, psychedelic-assisted psychotherapy, Psychiatry, RC435-571

الوصف: Background Randomised controlled trials (RCTs) of psilocybin have reported large antidepressant effects in adults with major depressive disorder and treatment-resistant depression (TRD). Given psilocybin's psychedelic effects, all published studies have included psychological support. These effects depend on serotonin 2A (5-HT2A) receptor activation, which can be blocked by 5-HT2A receptor antagonists like ketanserin or risperidone. In an animal model of depression, ketanserin followed by psilocybin had similar symptomatic effects as psilocybin alone. Aims To conduct a proof-of-concept RCT to (a) establish feasibility and tolerability of combining psilocybin and risperidone in adults with TRD, (b) show that this combination blocks the psychedelic effects of psilocybin and (c) provide pilot data on the antidepressant effect of this combination (compared with psilocybin alone). Method In a 4-week, three-arm, ‘double dummy’ trial, 60 adults with TRD will be randomised to psilocybin 25 mg plus risperidone 1 mg, psilocybin 25 mg plus placebo, or placebo plus risperidone 1 mg. All participants will receive 12 h of manualised psychotherapy. Measures of feasibility will include recruitment and retention rates; tolerability and safety will be assessed by rates of drop-out attributed to adverse events and rates of serious adverse events. The 5-Dimensional Altered States of Consciousness Rating Scale will be a secondary outcome measure. Results This trial will advance the understanding of psilocybin's mechanism of antidepressant action. Conclusions This line of research could increase acceptability and access to psilocybin as a novel treatment for TRD without the need for a psychedelic experience and continuous monitoring.

العلاقة: https://www.cambridge.org/core/product/identifier/S2056472423005355/type/journal_articleTest; https://doaj.org/toc/2056-4724Test; https://doaj.org/article/10ad65ed1a304a1986644921c7e8bc6cTest

الإتاحة: https://doi.org/10.1192/bjo.2023.535Test
https://doaj.org/article/10ad65ed1a304a1986644921c7e8bc6cTest

المؤلفون: Hiyam Al-Jabr, Lisa D. Hawke, David R. Thompson, Andrew Clifton, Mark Shenton, David J. Castle, Chantal F. Ski

المصدر: BMC Public Health, Vol 23, Iss 1, Pp 1-18 (2023)

مصطلحات موضوعية: Long COVID, Mental health, Optimal Health Programme, COVID-19, Integrated care, Public aspects of medicine, RA1-1270

الوصف: Introduction Long COVID (LC) is a multisystem disease with symptoms lasting weeks or months beyond the acute COVID-19 infection. Several manifestations are reported by people with LC, including effects on mental health, with varying degrees of psychological distress and disturbances to daily activities. Research conducted to identify effective interventions to support mental health among people with LC has been limited by the breadth and scope of studies. Aim This review aims to identify interventions being tested to support mental health of people with LC. Methods A scoping review was conducted by searching five databases for articles published between January 2020 and early October 2022 to identify research evaluating interventions focused on improving mental health symptoms associated with LC. Results from all sources were checked for eligibility by two reviewers, and agreements were resolved by discussion. Gray literature and reference list of included studies and relevant reviews were scrutinised to identify any additional studies. Data extraction was conducted by one reviewer and checked by another reviewer for accuracy. Results Of the 940 studies identified, 17 were included, the design of which varied but included mainly case studies (n = 6) and clinical trials (n = 5). Several interventions were described, ranging from single interventions (e.g., pharmacologic) to more holistic, comprehensive suites of services (pharmacologic and non-pharmacologic). Several mental health outcomes were measured, mostly anxiety and depression. All included studies were reported to be associated with improvements in participants’ mental health outcomes. Conclusion This scoping review identified studies reporting on a variety of interventions to support mental health among people with LC. Although positive changes were reported by all studies, some were case studies and thus their findings must be interpreted with caution. There is a need for more research to be conducted to identify the impact of interventions on ...

العلاقة: https://doi.org/10.1186/s12889-023-16079-8Test; https://doaj.org/toc/1471-2458Test; https://doaj.org/article/4c423b83ac034e37b3af1d326a08bf2cTest

الإتاحة: https://doi.org/10.1186/s12889-023-16079-8Test
https://doaj.org/article/4c423b83ac034e37b3af1d326a08bf2cTest

المؤلفون: Maya S. Sheth, David J. Castle, Wei Wang, Alina Lee, Zoe M. Jenkins, Lisa D. Hawke

المصدر: SSM - Mental Health, Vol 3, Iss , Pp 100190- (2023)

مصطلحات موضوعية: Coping, Chronic disease, Mental health, Psychosocial, Interventions, Mental healing, RZ400-408, Public aspects of medicine, RA1-1270

الوصف: Background: Adaptive-style coping strategies are associated with favourable mental health and quality of life outcomes among individuals with chronic disease. The Optimal Health Program (OHP) is a psychosocial self-efficacy program that empowers individuals to be active leaders in their health and wellness management. This study aimed to evaluate the impact of the OHP on coping styles. Methods: Adults with Type 1 or Type 2 diabetes, chronic kidney disease, stroke survivors, and stroke carers were recruited from St. Vincent's Hospital, Australia, to participate in one of three trials evaluating the efficacy of the OHP compared to usual care for the management of these chronic conditions. Coping was assessed at baseline, then at 3, 6- and 12-months post baseline. To examine changes in coping in association with OHP participation, we conducted a linear mixed-effects model, using the repeated measures approach. Results: The sample was comprised of 411 participants, with 76 (18.5%) stroke survivors, 69 (16.8%) stroke carers, 151 (36.7%) chronic kidney disease patients, and 115 (28.0%) diabetes mellitus patients. There were significant group by time interactions for problem-focused coping, instrumental support, positive reframing, and self-blame, indicating that participants in the OHP arm improved significantly more than those in the control group with regard to coping styles. Many interactions were significant at 3 and 6 months, but not 12 months. Conclusion: The OHP was successful in improving adaptive coping behaviours and decreasing maladaptive coping behaviours in the short-term, but the effects were not maintained at 12 months. Additional booster sessions may be helpful in sustaining intervention effects. This study serves as support for the importance of interventions targeting the psychosocial and physical health aspects of chronic disease to improve individuals’ overall wellbeing.

العلاقة: http://www.sciencedirect.com/science/article/pii/S2666560323000051Test; https://doaj.org/toc/2666-5603Test; https://doaj.org/article/b78422bf8f804fdfbdec9ee99d0495b6Test

الإتاحة: https://doi.org/10.1016Test/j.ssmmh.2023.100190
https://doaj.org/article/b78422bf8f804fdfbdec9ee99d0495b6Test